Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00776308 · ClinicalTrials.gov registry record

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
98
Enrollment target

NCT00776308: Completed study, sponsored by Mayo Clinic.

NCT00776308 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00776308 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
98 participants
Enrollment target

Study Summary

Conventional mammography is not a reliable method for determining the extent of disease in women with breast cancer. Molecular Breast Imaging (MBI) is a new nuclear medicine technique that allows the breast to be imaged in a manner similar to mammography, but without the pain of compression. Initial results with this method have shown it is very good at detecting small breast cancers (\~1/4 inch). The purpose of this study is to see if MBI is a better method than mammography in determining how much cancer is present before a woman goes to surgery. The study will comprise 120 women with breast cancer who are going to surgery. The investigators hope that this study will demonstrate that MBI will be more accurate in determining how much cancer is present.

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2008-10
Est. Completion 2011-02
Mayo Clinic

2,844 total trials

What the finished NCT00776308 record still lists

NCT00776308 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00776308 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00776308 about?

NCT00776308 is a clinical study titled "Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery". Conventional mammography is not a reliable method for determining the extent of disease in women with breast cancer. Molecular Breast Imaging (MBI) is a new nuclear medicine technique that allows the breast to be imaged in a manner similar to mammography, but without the pain of compression. Initial...

What is the current status of trial NCT00776308?

This trial is currently completed. The enrollment target is 98 participants. The study started on 2008-10. Estimated completion is 2011-02.

Who is sponsoring clinical trial NCT00776308?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02926729 · 98 participants · NA

    Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

  • NCT03382977 · 98 participants · Phase 1

    Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

  • NCT04577014 · 98 participants · Phase 1

    Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • NCT04817618 · 98 participants · Phase 3

    Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00776308, the US trial registry maintained by the National Library of Medicine. NCT00776308 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.